Respiratory Health Questions

Persistent cough (over 3 weeks), coughing up blood, breathlessness with activities you used to do easily, wheezing, chronic mucus production, recurrent chest infections, unexplained weight loss, fatigue, and chest pain. Any of these deserve medical evaluation. In India, persistent cough always warrants ruling out tuberculosis.

Aerobic exercise (walking, jogging, cycling, swimming) improves overall cardiopulmonary fitness. Breathing exercises (pranayama, diaphragmatic breathing) improve efficiency and are especially helpful for people with COPD or asthma. Playing wind instruments strengthens respiratory muscles. Stopping smoking is the biggest lung-health intervention. Lung capacity itself doesn't grow beyond genetic potential, but function within your capacity improves.

Not routinely for healthy asymptomatic adults. Useful if you have persistent respiratory symptoms, occupational exposure, long smoking history, or being evaluated for asthma or COPD. Spirometry is quick, painless, and provides genuine diagnostic information. A screening spirometry every few years can be reasonable for higher-risk individuals.

Fine particulate matter (PM2.5) is small enough to penetrate deep into lung tissue and even enter the bloodstream. Long-term exposure causes airway inflammation, reduced lung development in children, worse asthma control, higher COPD and lung cancer rates, and increased cardiovascular disease. Children and outdoor workers are most exposed. Effects accumulate over years, so annual peaks in polluted cities matter.

Good HEPA-filter purifiers with adequate CADR (clean air delivery rate) for the room size do reduce indoor PM2.5. Measurable benefit for children, asthmatics, and elderly in high-pollution cities. Not a substitute for outdoor measures (masks, avoiding outdoor exercise on bad AQI days) or systemic pollution reduction. A cheap small unit in a large room does little; matching capacity to room size matters.

Long-term exposure to high particulate matter (PM 2.5) increases risk of asthma, COPD, lung cancer, heart disease, and reduced lung function even in non-smokers. Delhi, Kolkata, and increasingly other cities regularly cross unhealthy levels. Protective measures: check daily AQI, use N95 masks outdoors on bad days, keep windows closed, indoor air purifiers for vulnerable people (children, asthmatics, elderly), and exercise indoors on high-pollution days.

See a doctor if a cough lasts more than 3 weeks, comes with unexplained weight loss, night sweats, blood in sputum, high fever, breathlessness, or chest pain. In India, persistent cough always needs to rule out tuberculosis. Cough that worsens at night in a child can suggest asthma. Sudden severe cough with breathlessness could be a foreign body or asthma attack.

Asthma typically causes recurrent episodes of wheezing, breathlessness, chest tightness, and cough — often worse at night, early morning, with exercise, allergens, or cold air. Diagnosis needs a lung function test (spirometry) — not just symptoms or a chest X-ray. Many people diagnosed as 'asthmatic' actually have allergic rhinitis, viral bronchitis, or GERD-related cough. A pulmonologist can sort out which.

No. Hookah/shisha exposes users to significant carbon monoxide, tar, and toxic chemicals — often more per session than a cigarette. Vaping is less harmful than cigarettes for existing smokers switching over, but not harmless — long-term effects are still being studied, and it's addictive. Neither is safe for non-smokers or young people to start.

Persistent cough (weeks not days), breathlessness with activities you used to do easily, wheezing, chest tightness, recurrent chest infections, unexplained weight loss, fatigue, and — later — blue-tinged fingertips or lips. Anyone with smoking history or significant pollution exposure should take these seriously. A spirometry test measures lung function and catches decline early.

Allergic rhinitis (from dust mites, pollen, mould, pet dander, cockroach droppings) is the most common cause. Non-allergic rhinitis from irritants, weather changes, or hormones is also common. Rarer: nasal polyps, deviated septum, chronic sinusitis. If symptoms persist most days for weeks, an ENT specialist or allergist can distinguish and guide treatment beyond over-the-counter antihistamines.

If symptoms are frequent, affecting sleep or quality of life, and unclear triggers — yes. Skin prick tests or specific IgE blood tests identify actual triggers. Random 'panel' tests without symptom correlation are often not useful. Testing is most helpful when it changes what you do (allergen avoidance strategy, targeted treatment, or immunotherapy consideration).

First line: nasal steroid sprays (fluticasone, budesonide) daily — often more effective than tablets. Add oral antihistamines for breakthrough symptoms. Avoiding triggers where possible (dust-proof pillow covers, keeping pets out of bedrooms, high-efficiency air purifier, wearing a mask outdoors during pollen season). For persistent severe symptoms, immunotherapy (allergy shots or drops) can gradually reduce sensitivity.

Cold: sudden onset with fever possible, thick coloured nasal discharge later, sore throat, resolves in 7-10 days. Allergic rhinitis: gradual, no fever, clear watery nasal discharge, itchy eyes/nose/throat, sneezing spells, can last weeks or seasons, often recurrent. Allergies are also often triggered by specific exposures (going outside, dust in the house, pet contact).

For dust mite, mould, pet dander, and outdoor pollution particles entering indoors: yes, HEPA-filter purifiers help — measurably so for larger units suited to room size. Not a substitute for allergen avoidance (dust-proof bedding, regular cleaning). Runs continuously in the room where you sleep for meaningful benefit. Cheap small units in large rooms don't do much.

For most adult-onset asthma, yes — but well-controlled asthma should not interfere with normal life, exercise, or sleep. Childhood asthma sometimes resolves or improves markedly in adulthood; other times it persists. The goal is good control (rare symptoms, no night-time waking, normal activity, normal lung function on testing) — not to 'cure' it.

Good control looks like: symptoms less than twice a week, no night-time waking from asthma, reliever inhaler needed less than twice a week, no limitation of activities. Poor control: frequent symptoms, night-time waking, frequent reliever use, missed work or school, hospital visits. If any of these describe you, your treatment needs adjustment — talk to your doctor rather than living with poor control.

For most people with persistent asthma: yes — a daily 'preventer' (usually inhaled corticosteroid) keeps airway inflammation down. Reliever inhalers (blue/salbutamol) are for quick symptom relief only. Over-reliance on relievers without preventer use is a common pattern — and dangerous, since it doesn't address the underlying inflammation. Combination inhalers (steroid + long-acting bronchodilator) are common maintenance.

Yes — inhaled steroids deliver very small doses directly to the airways and are safe for years of use in most people. Side effects (oral thrush, hoarse voice) are minor and preventable by rinsing your mouth after use. The risks of poorly controlled asthma (airway damage, life-threatening attacks) far outweigh the low risks of inhaled steroids. Don't stop them because you feel fine — feeling fine is the medicine working.

Individual triggers vary — common ones: allergens (dust mites, pollen, pet dander, mould, cockroaches), viral infections, cold air, exercise (though controlled asthma shouldn't prevent exercise), tobacco smoke, air pollution, strong fragrances, and — for some — aspirin/NSAIDs. Identify your own triggers by observation. Some triggers can be avoided; for others (pollution, cold air), pre-treatment with your inhaler before exposure helps.

Chronic obstructive pulmonary disease — a progressive lung condition causing airflow obstruction. Main causes: long-term smoking (biggest), long-term biomass fuel exposure (relevant in rural India where chulha smoke is a major cause, especially for women), long-term severe air pollution, and — less commonly — occupational dust or genetic factors (alpha-1 antitrypsin deficiency). Symptoms: progressive breathlessness, chronic cough, sputum production.

COPD is largely permanent airflow obstruction, typically in adults over 40 with a history of smoking or biomass exposure. Asthma is often reversible airflow obstruction, may start in childhood, often with allergic triggers, and lung function normalises between episodes. Some people have overlapping features (ACO — asthma-COPD overlap). Spirometry testing distinguishes them.

No — the lung damage doesn't reverse. But progression can be slowed dramatically by stopping smoking (or biomass exposure), taking prescribed inhalers, pulmonary rehabilitation (structured exercise programme), preventing infections through vaccinations, and treating exacerbations promptly. Even people with advanced COPD can significantly improve function and quality of life with proper care.

Long-acting bronchodilator inhalers (LABAs, LAMAs), inhaled corticosteroids for some, pulmonary rehabilitation (structured exercise proven to improve breathlessness), vaccinations (flu, pneumococcal, COVID), oxygen therapy for advanced cases, and — for a small subset — lung volume reduction or transplant. Stopping smoking is the single most impactful intervention at any stage.

Worsening breathlessness despite reliever use, increased sputum production or change to green/yellow, fever, chest pain, extreme fatigue, confusion, or blue-tinged lips or fingertips — all warrant urgent evaluation. Sudden severe attacks are dangerous. A home oxygen monitor (pulse oximeter) is useful for people with COPD; oxygen saturation dropping below 90% needs medical attention.

Sleep apnea is repeated pauses in breathing during sleep — most commonly from throat tissue collapse (obstructive sleep apnea). Signs: loud snoring, gasping or choking during sleep, waking unrefreshed, daytime sleepiness, morning headaches, mood changes. Left untreated, it raises risk of hypertension, heart disease, stroke, diabetes, and accidents from daytime fatigue. Very common in India — especially in men with abdominal obesity.

A sleep study (polysomnography, or a simpler home sleep test) is the diagnostic test. Your partner's observations are often the first clue — loud snoring with pauses, or gasping episodes. Excessive daytime sleepiness, morning headaches, and poor concentration warrant evaluation. Not everyone who snores has sleep apnea, but sleep apnea usually causes snoring.

Continuous Positive Airway Pressure — a machine that keeps airways open with gentle pressurised air through a mask during sleep. It's the most effective treatment for moderate-severe obstructive sleep apnea. Adherence is the biggest challenge — the mask takes getting used to. Modern machines are quiet and small. Most people who stick with it feel dramatically better within weeks.

For obesity-related sleep apnea (very common), losing 10-15% of body weight often significantly improves or even resolves sleep apnea. Doesn't work for everyone or every form of sleep apnea (some have anatomical causes). Weight loss should be alongside — not instead of — treating current sleep apnea, since untreated sleep apnea makes weight loss harder (poor sleep disrupts appetite hormones).

Weight loss, avoiding alcohol close to bedtime (relaxes throat muscles), avoiding sedatives, sleeping on your side (positional therapy) rather than back, treating nasal congestion, and quitting smoking (reduces upper airway inflammation). These help but usually don't replace CPAP for moderate-severe cases. Sleep hygiene (consistent schedule, dark cool room, no screens before bed) helps sleep quality generally.

The most successful approach combines behavioural support (counselling, quit apps, quit-lines) with medication (nicotine replacement — patches, gum, lozenges; or prescription drugs like varenicline or bupropion). India's national tobacco quit-line (1800-11-2356) is free. Willpower alone has under 5% quit rates; combined approaches reach 25-30% one-year quit rates. Multiple attempts are normal — each attempt increases eventual success.

For existing smokers who can't quit with proven methods, switching to vaping is likely less harmful than continuing cigarettes — but not harmless. Vapes are addictive, and long-term effects are still being studied. India has banned e-cigarettes, limiting availability. Better path: use approved nicotine replacement (patches, gum) plus counselling. Don't take up vaping if you don't already smoke.

Fast. Within 20 minutes: heart rate drops. Within 24 hours: carbon monoxide levels normalise. 2 weeks-3 months: circulation and lung function improve, exercise gets easier. 1 year: heart disease risk drops significantly. 5-10 years: lung cancer risk falls to about half a smoker's. 15 years: heart disease risk approaches non-smoker. Every day quit adds up.

Many people gain 3-5 kg on average — nicotine suppresses appetite and mildly raises metabolism. Some gain more. The health benefit of quitting vastly exceeds the harm from moderate weight gain — this shouldn't stop you quitting. Prepare with a plan: healthier snacks handy, regular activity during the quit window, and staying hydrated. Weight gain slows and often reverses over 6-12 months.

Neither is easier; both are strongly addictive. Chewing tobacco (gutka, khaini, zarda, paan with tobacco) is often more addictive per exposure because delivery is prolonged. Same evidence-based approach applies — behavioural support plus nicotine replacement or medication. India has particularly high oral cancer rates from chewing tobacco; quitting reduces risk substantially, especially in the first 5-10 years.

GOLD (Global Initiative for Chronic Obstructive Lung Disease) staging classifies COPD severity by FEV1 post-bronchodilator spirometry as a percentage of predicted: GOLD 1 (mild): FEV1 ≥80% — most patients are unaware of COPD; nursing focus is early diagnosis, smoking cessation support, and flu/pneumococcal vaccination. GOLD 2 (moderate): FEV1 50–79% — breathlessness on exertion, often first triggers medical attention; NCP adds short-acting bronchodilators (SABA + SAMA), pulmonary rehabilitation referral, and pacing education. GOLD 3 (severe): FEV1 30–49% — significant breathlessness limiting daily activities; NCP adds long-acting bronchodilators (LAMA + LABA), review for inhaled corticosteroid combination, SpO2 home monitoring, and advance care planning initiation discussion. GOLD 4 (very severe): FEV1 <30% — frequent exacerbations, risk of respiratory failure; NCP adds long-term oxygen therapy assessment, palliative care referral if appropriate, and exacerbation action plan documented and laminated. Assessment additions for each stage: GOLD 1–2: six-minute walk test (6MWT) to quantify functional limitation; GOLD 3–4: MRC Dyspnoea Scale, Borg scale during activity, BODE index (Body-mass-index, Obstruction, Dyspnoea, Exercise — predicts mortality better than FEV1 alone). Exacerbation history matters more than FEV1 alone: GOLD reclassified to ABCD groups incorporating exacerbation frequency — a GOLD 2 patient with 2+ exacerbations/year is high-risk (Group C/D) and needs a different NCP than a GOLD 2 patient who has never been hospitalised. Update the NCP after every exacerbation: an exacerbation accelerates FEV1 decline and is the most preventable driver of COPD progression.

You can use homeopathy alongside conventional asthma treatment — and that is the medically responsible approach. Stopping your prescribed inhalers to switch to homeopathy alone is genuinely dangerous: asthma attacks can be fatal, and no homeopathic remedy has been shown to replace bronchodilator action in an acute exacerbation. Here's a practical way to think about it: inhalers are your safety net (reliever/preventer), and homeopathy can be explored as a complementary support for overall symptom frequency and constitution. Many integrative pulmonologists in India's larger hospitals (AIIMS, Christian Medical College Vellore, Manipal) are open to discussing homeopathic adjuncts as long as the patient's inhaler adherence is maintained and peak flow monitored. The Central Council for Research in Homeopathy (CCRH) in India has some ongoing studies on asthma — outcomes pending. If you are currently well-controlled on a low-dose inhaled corticosteroid, discuss with both your pulmonologist and a registered BHMS/MD homeopath before making any changes.

Some foods have reasonably good evidence for benefit — not miracle cures, but consistent support from clinical data. (1) Omega-3 fatty acids (fatty fish, flaxseeds, walnuts): reduce leukotriene production — leukotrienes are the chemical mediators that trigger bronchospasm in allergic asthma. A 2019 Cochrane review found higher omega-3 intake associated with reduced emergency asthma visits. Indian fish: mackerel (bangda), sardines, rohu, and katla are affordable, high-omega-3 options. (2) Vitamin D-rich foods (egg yolks, fortified milk, sunlight): vitamin D deficiency is associated with more severe asthma and worse steroid response. Around 70% of Indians are deficient. A 2017 Cochrane review found supplementation reduced severe asthma attacks by 50%. Get your 25(OH)D level checked — if below 20 ng/mL, supplementation is needed. (3) Magnesium (nuts, seeds, leafy greens, whole grains): magnesium relaxes bronchial smooth muscle (intravenous magnesium is actually used in emergency asthma treatment). Higher dietary magnesium intake is associated with better FEV1. (4) Apples (quercetin, flavonoids): observational studies find higher apple consumption correlated with fewer asthma episodes — attributed to quercetin's anti-inflammatory effect on mast cells. Note: these are supportive, not replacement therapies. Your inhaler comes first.

Yes, significantly — and this is one of the most underappreciated asthma interventions. Obesity independently worsens asthma through multiple mechanisms: (1) mechanical — abdominal fat pushes the diaphragm upward, reducing lung volume (FRC) and making breathing at rest require more effort; (2) inflammatory — adipose tissue secretes pro-inflammatory cytokines (leptin, TNF-α, IL-6) that amplify airway inflammation; (3) GERD — obesity increases reflux, and stomach acid in the oesophagus reflexively triggers bronchospasm. Studies show that for obese asthma patients, every 10% weight loss improves FEV1 by approximately 7% and reduces rescue inhaler use by 30–40%. In India, yoga (pranayama + posture work) has been shown in multiple RCTs to improve asthma control scores and reduce medication need — partly through weight and partly through direct respiratory muscle training. The effect size is modest but meaningful: about equivalent to stepping up from a low-dose to a medium-dose inhaled corticosteroid. If you're overweight with poorly controlled asthma, weight management deserves as much attention as inhaler adherence in your care plan.

Yes — the type of organism determines both the clinical picture and the antibiotic choice. Typical bacterial pneumonia (Streptococcus pneumoniae, Haemophilus influenzae): starts abruptly — sudden high fever (39–40°C), rigor (shaking chills), productive cough with rust-coloured or purulent sputum, pleuritic chest pain (sharp pain worsening with deep breath, from pleural involvement). CXR shows lobar or segmental consolidation. Responds well to amoxicillin or beta-lactam antibiotics. Atypical pneumonia (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella): more gradual onset over several days, lower fever, dry or minimally productive cough (often described as a 'walking pneumonia' because patients may remain ambulatory), prominent extrapulmonary features — headache, myalgia, sore throat. CXR often shows interstitial or bilateral patchy infiltrates without clear lobar consolidation. Crucially: Mycoplasma has no cell wall, so penicillins and cephalosporins don't work. Treatment requires a macrolide (azithromycin, clarithromycin) or doxycycline. The clinical significance in India: Mycoplasma is particularly common in young adults aged 5–35, spreads in schools and colleges, and is a common cause of 'antibiotic not working' cases where amoxicillin was correctly prescribed but for the wrong organism. Viral pneumonia (influenza, SARS-CoV-2, RSV) can mimic atypicals but has distinct epidemiological patterns and responds to antivirals rather than antibiotics.

The outcome of any pneumonia is shaped by the contest between the pathogen's virulence and the host's defences. On the pathogen side: Streptococcus pneumoniae (the most common cause of bacterial pneumonia) produces polysaccharide capsules that resist phagocytosis, pneumolysin toxin that disrupts alveolar membranes, and can rapidly multiply to overwhelming numbers. More aggressive organisms mean more damage before defences can mount. On the host side, several factors impair the respiratory defence system: (1) Mucociliary escalator: cilia lining the airways sweep pathogens upward; cigarette smoke paralyses cilia within minutes — even occasional smokers have compromised escalator function, explaining why smokers get pneumonia more often and more severely. (2) Alveolar macrophages: the resident immune cells in the alveoli are the first line of phagocytosis; alcohol impairs macrophage function significantly — heavy drinkers have 3–4× higher pneumonia risk. (3) Immunosuppression: steroid use, diabetes (which impairs neutrophil function), HIV, and cancer treatment all reduce the immune response. (4) Structural lung disease: COPD, bronchiectasis, or post-TB fibrosis leave areas of the lung with impaired drainage and mechanical clearance. (5) Age: infants (immune system immature) and the elderly (T-cell function declines with age) are at each extreme. In India, malnutrition compounds all of these — a protein-deficient child has impaired secretory IgA production, reduced complement activity, and weakened macrophage function. This is why pneumonia kills 400,000+ Indians annually, predominantly children under 5 and adults over 65.

Pneumonia is fundamentally a problem of alveolar flooding. The alveoli are tiny air sacs where oxygen and CO2 exchange occurs through a thin membrane — in a healthy lung, this membrane is essentially dry and gas passes freely. When a pathogen (bacteria, virus, or fungus) enters the lung and overwhelms local defences, the immune system launches an inflammatory response: blood vessels dilate and become leaky, and inflammatory fluid (exudate) pours into the alveolar space. The alveolus fills with protein-rich fluid and immune cells. Once flooded, that alveolus can no longer participate in gas exchange — blood passing through is not oxygenated. This creates ventilation-perfusion (V/Q) mismatch: blood perfuses areas of the lung that are not ventilating, returning to the heart deoxygenated. As more alveoli fill, SpO2 falls. This is why pneumonia can cause hypoxia even though the rest of the lung is fine. The body responds by increasing respiratory rate (tachypnoea) to compensate — which is why fast breathing is one of the most sensitive early warning signs. In severe pneumonia, the flooding extends to multiple lobes; when the respiratory muscles fatigue from the increased work of breathing, respiratory failure can follow. This is the pathway from 'chest infection' to ICU admission that happens over hours to days — catching early signs (RR >24, SpO2 falling, confusion) is what enables intervention before the cascade completes.

Physiological discharge criteria (all should be met): SpO2 ≥92% on room air (or stable on prescribed home oxygen if pre-existing); temperature <37.8°C for at least 24 hours without antipyretics; respiratory rate <24/min; heart rate <100/min; blood pressure within normal range; tolerating oral fluids and medications. Additional readiness indicators: conscious and oriented, able to communicate needs, able to mobilise safely (or safe home support arrangements in place for those with mobility limitations). Common discharge-too-early error in India: patients request early discharge before the physiological criteria are met — nursing's role is to communicate these objective thresholds clearly to the treating team and to families. Discharge education for patients and caregivers (TEACH-BACK every point): (1) Complete the full antibiotic course — typically 5–7 days for CAP; stopping early when feeling better is the commonest cause of relapse; (2) Return-to-ED warning signs: worsening breathlessness, SpO2 dropping below 92% on home pulse oximeter, temperature returning after resolution, confusion, inability to swallow medications; (3) Follow-up chest X-ray: a repeat CXR in 6–8 weeks confirms radiological clearance — this is especially important to rule out underlying malignancy in smokers over 40 where pneumonia can be the presenting event of a tumour; (4) Vaccination: pneumococcal vaccine (Pneumovax 23) and annual influenza vaccine — both free under Universal Immunisation Programme for high-risk groups; (5) Smoking cessation referral: give Quitline number 1800-112-356; (6) Hydration goal: 2–2.5 L/day to keep secretions thin during recovery.

Home remedies alone are not enough to treat pneumonia — you need a doctor's assessment first. Bacterial pneumonia (the most common type) requires antibiotics; viral pneumonia requires antiviral or supportive care depending on severity. Attempting to 'treat' pneumonia with only steam inhalation or honey-lemon tea while avoiding a diagnosis is genuinely dangerous — pneumonia kills around 400,000 Indians annually, and most of those deaths occur when treatment is delayed. What home remedies DO help: steam inhalation relieves congestion and makes breathing slightly easier; honey-lemon in warm water soothes throat irritation; adequate hydration (2–3 litres/day of water, broths, warm herbal teas) helps thin mucus secretions; rest allows the immune system to work efficiently. Use these alongside prescribed treatment, not instead of it. If you've been diagnosed with mild community-acquired pneumonia (CAP) and the doctor has cleared you for home management, these supportive measures can meaningfully speed up recovery.

Fluids first — aim for at least 2–2.5 litres/day: warm water, fresh vegetable soups (dal water, bottle gourd/lauki soup), coconut water, and warm herbal teas (ginger-tulsi, mulethi/licorice root). These thin mucus and support expectoration. For food: prioritise protein-rich meals (dal, eggs, curd, paneer, fish) because your immune system needs amino acids for antibody production and tissue repair. Vitamin C-rich foods (amla, guava, orange, lemon) support white blood cell function. Zinc from pumpkin seeds, legumes, and whole grains reduces inflammation. What to avoid: heavy, oily, or fried food (hard to digest when already oxygen-compromised), alcohol (dehydrates and suppresses immune response), and cold drinks or ice cream (may aggravate coughing). Small frequent meals are better than three large ones — diaphragm pressure after a full meal can worsen breathlessness.

Most healthy adults with mild to moderate community-acquired pneumonia feel meaningfully better within 5–7 days of starting antibiotics. However, full recovery — returning to normal energy levels without breathlessness — typically takes 3–6 weeks. A useful rule: fever and productive cough should begin improving by Day 3–5. If they don't, that's a sign the treatment isn't working or the pathogen isn't responding — go back to your doctor. X-ray clearance takes longer than symptom clearance — a chest X-ray often still shows infiltrates at 6–8 weeks even when a patient feels well. Older adults (65+), people with diabetes or COPD, and smokers typically recover more slowly. For this group, doctor-monitored home recovery with a follow-up appointment at 2 weeks is the standard approach.

Seven warning signs require same-day emergency care — do not wait until morning: (1) breathing rate faster than 30 breaths per minute at rest; (2) lips, fingernails, or skin turning bluish (cyanosis) — indicates critically low oxygen; (3) confusion, extreme drowsiness, or altered consciousness, especially in elderly patients; (4) SpO2 below 92% on pulse oximeter at home; (5) inability to keep fluids down due to vomiting (antibiotic medication can't be retained); (6) no improvement after 48–72 hours on prescribed antibiotics; (7) severe chest pain making normal breathing impossible. In India, call 108 (national ambulance service) or take the patient to the nearest government hospital emergency immediately. Do not apply steam or give home remedies in this state — these are signs of severe pneumonia (CURB-65 score 3+) that can deteriorate rapidly without IV antibiotics and oxygen.

The assessment has three layers. (1) History: how often does the patient wheeze or cough? Does it wake them at night? How frequently are they using their rescue inhaler (salbutamol)? Using a rescue inhaler more than twice a week signals poorly controlled asthma. What are their known triggers — dust mites, pollen, pet dander, exercise, cold air, viral infections, smoke? (2) Physical exam: listen for wheeze (polyphonic = diffuse bronchospasm; monophonic = partial obstruction like foreign body) and use of accessory muscles. Check SpO2 — below 92% indicates severe exacerbation requiring immediate escalation. (3) Lung function: spirometry confirms diagnosis (FEV1/FVC <0.7 post-bronchodilator with >12% reversibility confirms asthma). Peak flow measurement tracks day-to-day variability — a drop of >20% below personal best is an early warning sign. Allergy skin-prick testing or IgE panel identifies specific triggers. In India, affordable spirometry is available at government medical college respiratory departments (₹200–500) and private pulmonology clinics.

This is one of the most impactful nursing interventions in asthma — studies show >60% of patients use MDIs incorrectly, making their medication largely ineffective. The teach-back method is the gold standard: nurse demonstrates, patient demonstrates back, nurse corrects. For a metered-dose inhaler (MDI): (1) shake well before use; (2) exhale fully away from inhaler; (3) seal lips around mouthpiece; (4) press canister and begin slow deep inhale simultaneously (the single most common error is pressing first then inhaling, which delivers only 10% to the lungs); (5) hold breath 10 seconds; (6) wait 30–60 seconds before second puff. Always recommend a spacer (₹150–400 at pharmacies) — spacers increase drug deposition in the lungs by 40–50% and are particularly important for children and elderly patients. For dry-powder inhalers (Rotacap, Rotahaler), inhale forcefully — different from MDI. Verify at every follow-up visit. A patient who has been on the same inhaler for years may have developed bad habits they're unaware of.

The most effective asthma action plans use a traffic-light (green/yellow/red) system tied to symptoms or peak flow readings. Green zone (peak flow 80–100% of personal best): continue regular medications, no limitations on activity. Yellow zone (peak flow 50–79%): asthma is getting worse. Start oral prednisolone if prescribed, increase rescue inhaler to 4–8 puffs every 20 minutes for 3 doses, call doctor within 24 hours. Red zone (peak flow <50%): medical emergency. Use rescue inhaler immediately, take oral prednisolone if available, go to hospital or call 108 ambulance if no improvement after 15 minutes. The plan must include: patient's personal best peak flow (measured when stable), list of identified triggers, emergency contact number, nearest hospital or emergency department. In India, GINA's free action plan template in Hindi and other regional languages is available from your pulmonologist or download from ginaasthma.org. The plan should be written down, not just discussed — discharge recall of verbal-only instructions is less than 30%.